Hypoxia Inhibits Osteogenesis and Promotes Adipogenesis of Fibroblast-like Synoviocytes via Upregulation of Leptin in Patients with Rheumatoid Arthritis
Open Access
- 7 December 2022
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-11
Abstract
Hypoxia is associated with the pathogenesis of rheumatoid arthritis (RA). RA fibroblast-like synoviocytes (FLSs) are able to differentiate into osteoblasts and adipocytes. In this study, we aimed to investigate the role of hypoxia in the osteogenesis or adipogenesis of RA-FLSs. Bioinformatics analysis was performed to profile gene expression in the datasets of GSE21959, GSE32006, and GSE55875, and flow cytometry was performed for FLS characterization, while Alizarin Redand Oil Red O staining for osteogenic or adipogenic differentiation of FLSs, respectively. RNA interference leptin knockdown was used to determine the role of leptin in the osteogenesis and adipogenesis of RA-FLSs, and the expression of osteogenic and adipogenic markers was quantified by RT-qPCR and Western blotting. FLSs exhibited a mesenchymal stem cell (MSC)-like phenotype and we observed a limited self-renewal capacity in RA-FLSs compared to that in MSCs, but it was still greater than osteoarthritis (OA)-FLSs. Hypoxia did not change the RA-FLS MSC-like phenotype but inhibited the osteogenic differentiation and promoted the adipogenic differentiation of RA-FLSs. From the bioinformatics analysis ofGSE21959, GSE32006, and GSE55875 datasets, we found leptin, the only perturbed hypoxia-mediated upregulated gene across the three profiled datasets. Leptin knockdown in RA-FLSs reversed the hypoxia-mediated reduction of osteogenesis and hypoxia-mediated enhancement of adipogenesis by elevated expression of osteogenic markers and reduced expression of adipogenic markers, respectively. Therefore, hypoxia-leptin regulation of the osteogenic and adipogenic differentiation of RA-FLSs advances our understanding of RA pathogenesis, meanwhile also provides opportunities for future therapeutic intervention of RA.Keywords
Funding Information
- Talent Development Program of “new star of medicine” (087, 82001725, 81971535, 81801616)
- National Natural Science Foundation of China (087, 82001725, 81971535, 81801616)
This publication has 35 references indexed in Scilit:
- Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RAArthritis Research & Therapy, 2012
- Hypoxia Inhibits Osteogenesis in Human Mesenchymal Stem Cells through Direct Regulation of RUNX2 by TWISTPLOS ONE, 2011
- Tumor necrosis factor blocking therapy alters joint inflammation and hypoxiaArthritis & Rheumatism, 2011
- Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic conditionJournal of Cellular Biochemistry, 2010
- Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cellsBMC Cell Biology, 2010
- IL-6 receptor expression and IL-6 effects change during osteoblast differentiationCytokine, 2008
- An essential role of NF-κB in the “tumor-like” phenotype of arthritic synoviocytesProceedings of the National Academy of Sciences, 2006
- Leptin Treatment Induces Loss of Bone Marrow Adipocytes and Increases Bone Formation in Leptin-Deficient ob/ob MiceJournal of Bone and Mineral Research, 2005
- Leptin Inhibits Bone Formation through a Hypothalamic RelayCell, 2000
- Positional cloning of the mouse obese gene and its human homologueNature, 1994